Results 1 to 10 of about 5,690,964 (274)

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.

New England Journal of Medicine, 2022
BACKGROUND Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non-small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have shown promising clinical activity; however ...
P. Forde, J. Spicer, Shun Lu, M. Provencio, T. Mitsudomi, M. Awad, E. Felip, S. Broderick, J. Brahmer, S. Swanson, K. Kerr, Changli Wang, T. Ciuleanu, G. Saylors, F. Tanaka, H. Ito, Keke Chen, M. Liberman, E. Vokes, J. Taube, C. Dorange, Junliang Cai, J. Fiore, A. Jarkowski, D. Balli, M. Sausen, D. Pandya, C. Calvet, N. Girard   +28 more
semanticscholar   +1 more source

The blood proteome of imminent lung cancer diagnosis

Nature Communications, 2023
Identification of risk biomarkers may enhance early detection of smoking-related lung cancer. We measured between 392 and 1,162 proteins in blood samples drawn at most three years before diagnosis in 731 smoking-matched case-control sets nested within ...
The Lung Cancer Cohort Consortium (LC3)
doaj   +1 more source

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study

Frontiers in Oncology, 2021
BackgroundTo investigate the differences in survival between lobectomy and sub-lobar resection for elderly stage I non-small-cell lung cancer (NSCLC) patients using the Surveillance, Epidemiology, and End Results (SEER) registry.MethodThe data of stage ...
Bo Zhang, Renwang Liu, Dian Ren, Xiongfei Li, Yanye Wang, Huandong Huo, Shuai Zhu, Jun Chen, Jun Chen, Zuoqing Song, Zuoqing Song, Song Xu, Song Xu   +12 more
doaj   +1 more source

Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis

Cancer Medicine, 2023
Objective This study evaluated whether sublobar resection (sub‐L) is non‐inferior to lobectomy (L) for stage I (T1‐T2aN0M0) small cell lung cancer (SCLC) regarding long‐term overall survival (OS).
Ning Zhou, Lingqi Yang, Bo Zhang, Shuai Zhu, Huandong Huo, Jinling He, Lingling Zu, Zuoqing Song, Song Xu   +8 more
doaj   +1 more source

Lung cancer immunotherapy: progress, pitfalls, and promises

Molecular Cancer, 2023
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy.
Aritraa Lahiri, Avik Maji, P. Potdar, Navneet Singh, P. Parikh, B. Bisht, Anubhab Mukherjee, M. Paul   +7 more
semanticscholar   +1 more source

Clinical significance of preoperative neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio in the prognosis of resected early‐stage patients with non‐small cell lung cancer: A meta‐analysis

Cancer Medicine, 2023
Background Poor prognosis is linked to peripheral blood levels of preoperative platelet‐lymphocyte ratio (PLR) and neutrophil‐lymphocyte ratio (NLR) in many advanced cancers. Nevertheless, whether the correlation exists in resected early‐stage cases with
Weibo Cao, Haochuan Yu, Shuai Zhu, Xi Lei, Tong Li, Fan Ren, Ning Zhou, Quanying Tang, Lingling Zu, Song Xu   +9 more
doaj   +1 more source

To Explore the Effects of Acupuncture and Medical Treatment at Different Times on the Gastrointestinal Reaction and White Blood Cell Count of Patients with Lung Cancer Chemotherapy

Applied Bionics and Biomechanics, 2022
Objective. To explore and analyze the effects of acupuncture and medical treatment at different times on the gastrointestinal reaction and leukocyte count of patients with lung cancer undergoing chemotherapy. Methods.
Qingchun Zhao, Hui Du, Jinghao Liu, Yu Hua, Xiaoyu Niu, Jun Chen   +5 more
doaj   +1 more source

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis

Frontiers in Genetics, 2022
Although RAD51 associated protein 1 (RAD51AP1) is crucial in genome stability maintenance, it also promotes cancer development with an unclear mechanism.
Renwang Liu, Renwang Liu, Guangsheng Zhu, Guangsheng Zhu, Mingbiao Li, Peijun Cao, Peijun Cao, Xuanguang Li, Xuanguang Li, Xiuwen Zhang, Xiuwen Zhang, Hua Huang, Hua Huang, Zuoqing Song, Zuoqing Song, Jun Chen, Jun Chen   +16 more
doaj   +1 more source

Early Diagnosis of Lung Cancer Using Computer Aided Detection via Lung Segmentation Approach [PDF]

International Journal of Engineering Trends and Technology 69.5(2021):85-93, 2021
Lung cancer begins in the lungs and leading to the reason of cancer demise amid population in the creation. According to the American Cancer Society, which estimates about 27% of the deaths because of cancer. In the early phase of its evolution, lung cancer does not cause any symptoms usually.
arxiv   +1 more source

MDT Treatment of Small Cell Lung Cancer Complicated with Adenocarcinoma: 
A Case Report and Literature Review

Chinese Journal of Lung Cancer, 2021
Small cell lung cancer (SCLC) is the most malignant lung cancer with the highest mortality. At present, the first-line standard treatment is still based on Etoposide and Platinum chemotherapy.
Zihan QU, Jiewei LIU, Feng LUO, Lu LI, Lingling ZHU, Qinghua ZHOU   +5 more
doaj   +1 more source